ADHD Medication Shortage: Current Status and What Changed
· 6 min read
Several ADHD stimulants are still on FDA's shortage list. Here is the timeline, what DEA changed, and where to check the live status.
Practical guides for finding medications during shortages — ADHD stimulants, GLP-1s, controlled substance transfers, savings, and how Needle works. Product updates
· 6 min read
Several ADHD stimulants are still on FDA's shortage list. Here is the timeline, what DEA changed, and where to check the live status.
· 6 min read
A different manufacturer's generic, or the brand, may be an option when your medication is out. Here is how substitution rules work and what to ask.
· 6 min read
General AI assistants can't see live pharmacy inventory. Here is what they can help with, and how a connector can hand off to a real phone-call search.
· 7 min read
A 2023 DEA rule allows a one-time electronic transfer of controlled substance prescriptions between pharmacies. Here is how it works in real life.
· 7 min read
The GLP-1 shortages are officially over, but finding your exact strength can still take work. Here is what changed and how to look.
· 7 min read
Pharmacy-is-out calls take staff time. Here is a simple workflow, the DEA transfer rules in brief, and where Needle for Providers fits.
· 6 min read
A simple phone script, a checklist of what to have ready, and what to do when a pharmacy won't confirm stock for a controlled medicine.
· 7 min read
Adderall is still on FDA's shortage list, but stock varies by pharmacy and manufacturer. Here is a calm, step-by-step way to find it.
· 6 min read
Vyvanse generics have been on the market since 2023, yet stock still varies. Here is how to check capsules and chewables across pharmacies.
· 3 min read
Connect Needle to your AI assistant and it can pin down your exact medication, check the FDA shortage list, and hand you off to a Needle search.
· 6 min read
A step-by-step checklist for the moment a pharmacy tells you your medication is out of stock, for any drug.
· 6 min read
Savings cards can lower a cash price, but they are not insurance and they rarely combine with it. Here is what to know before you use one.

· 8 min read
GLP-1 trials lean toward fewer strokes, SGLT2 trials show no clear stroke benefit, and evidence in stroke survivors is still limited. Here is what the research shows.

· 7 min read
FDA's 2025 list includes prescription apps for ADHD, insomnia, depression, anxiety, and substance use disorder. Here is how they work and what the evidence shows.

· 7 min read
FDA declared the Ozempic and Wegovy shortage resolved on February 21, 2025, but one strength can still run out at one pharmacy. Here is the full story.

· 7 min read
FDA found 62% of studied shortages followed manufacturing or quality problems. Here is why shortages happen and how phone searches help you find stock.

· 6 min read
A medication finder helps you learn which pharmacy has your drug in stock. Here are the main kinds, what each does well, and where each falls short.

· 7 min read
A shortage is easier to handle when you plan early. Here is how to check FDA's list, time refills, ask about longer supplies, and work with your prescriber.

· 7 min read
About 7 million U.S. children and 6.0% of adults have a current ADHD diagnosis. Here is how ADHD is diagnosed and how families and friends can help.

· 6 min read
An empty shelf is usually a local problem. These five steps, from a simple phone call to a calling service, help you find the pharmacy that has your medicine.

· 6 min read
Needle phones pharmacies for you and reports which ones say they have your exact drug, strength, and form. Here is the whole process, step by step.

· 8 min read
GLP-1 medicines began with a Gila monster peptide and FDA's 2005 approval of exenatide. Here is the timeline, today's options, and why access can be hard.

· 7 min read
From Charles Bradley's 1937 Benzedrine study to Ritalin in 1955 and non-stimulants in 2002 and 2021, here is how ADHD medicine developed.